Integrated Electrowetting Nanoinjector and Aspirator
- 技術優勢
- Only technique capable of direct transfection or extraction from within cell nucleus100% transfection efficiency Capable of tracking protein expression in response to external stimuli (e.g., drugs)Can inject DNA vectors into nucleus/ cytoplasm of living cellsCell remains viable after injection/ extractionWorks in mouse fibroblasts and fruit fly body fat cellsControlled volume delivery via applied differential voltage between the two solutions
- 技術應用
- · Nanoinjection of plasmids, antibodies, dyes into single cells · Nuclear injection to transfect single cells · Wide field fluorescence viewing · Single cell mRNA/protein analysis and drug interaction studies · Genetic manipulation of small model organisms for developmental cell biology studies
- 詳細技術說明
- Advancement of gene therapy application pushed the needs for novel and more efficient techniques to deliver DNA as well as macromolecules into cells. Accordingly, several methods were developed at both the bulk cell and the single cell levels. Viral and chemical transfections are the most common techniques recently used, however, they lack dosage control and ability to deliver to single cell. Moreover, available solutions have low transfection efficiency, inflammatory side effects and are highly expensive. Increased cell damage with decreased pipette aperture (nanoscale) due to high pressure to eject from pipette is also anther concerned to be addressed. Researchers at UCI developed a simple integrated electrowetting nano-injector that injects material into single cell with high transfection efficiency, controlled dosage delivery and most importantly with full cell viability. With transfection efficiency reaching 100% and very little disruption caused to the nuclear membrane, this novel method is definitely offering an efficient and safe alternative for the now emerging gene therapy applications, expanding the boundaries and possibilities for them.
- *Abstract
-
Gene therapy applications necessitate cell transfection techniques for delivering biomaterial into multiple or a single cell(s). The global market for transfection technologies can be worth more than half a billion by 2017. Current viral and chemical transfection techniques have limited ease of fabrication, transfection efficiency, dosage control, and cell viability. The invention discloses a simple yet efficient technique for nanoinjection of material into a single cell with high transfection efficiency, controlled dosage delivery, and full cell viability.
- *Principal Investigation
-
Name: Elaheh Shekaramiz
Department:
Name: Hemantha Wickramasinghe
Department:
- 其他
-
State Of Development
Demonstrated a working prototype , plans to further develop as part of an existing spin-off from UCI on genetic quantification.
Related Materials
Tech ID/UC Case
28776/2017-810-0
Related Cases
2017-810-0
- 國家/地區
- 美國
